Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1651
This examiner grants 53% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18000183 | Treatment Of Homocystinuria And Hyperhomocysteinemia Using Cystathionine-Gamma-Lyase | Final Rejection | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
| 18259212 | FUNGAL TEXTILE MATERIALS AND LEATHER ANALOGS | Non-Final OA | THE FYNDER GROUP, INC. |
| 18592050 | BOTULINUM NEUROTOXIN A SUBTYPE 6 AND PHARMACOLOGICAL METHODS OF USE | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18002670 | PROBIOTIC COMPOSITION FOR TOPICAL USE | Final Rejection | BIOGAIA AB |
| 17910105 | MATERIALS AND METHODS FOR THE TREATMENT OF GAUCHER DISEASE | Final Rejection | Children's Hospital Medical Center |
| 17092148 | FORMULATIONS AND DOSES OF PEGYLATED URICASE | Final Rejection | Selecta Biosciences, Inc. |
| 18246681 | A NOVEL PHAGE FOR LISTERIA, INCLUDING LISTERIA MONOCYTOGENES | Non-Final OA | Micreos Food Safety B.V. |
| 18044094 | DNA-COLLAGEN COMPLEXES AND MAGNETOELECTRIC JANUS MATERIALS FOR BIOMEDICAL APPLICATIONS | Non-Final OA | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION |
| 17916815 | METHODS OF IMPROVING HEALTH OF YOUNG RUMINANTS | Non-Final OA | The National Institute for Biotechnology in the Negev Ltd. |
| 18022091 | HYALURONIDASE FUSION PROTEINS COMPRISING A TARGETING SEQUENCE AND METHODS OF USING SAME TO TREAT A COSMETIC CONDITION | Final Rejection | STANDARD OF CARE CORPORATION |
| 18162541 | Antimicrobial Compositions and Related Methods of Use | Final Rejection | Jeneil Biosurfactant Company, LLC |
| 17127631 | COCKTAIL COMPOSITIONS COMPRISING RESPIRATORY ANTIBACTERIAL PHAGES AND METHODS OF USE THEREOF | Non-Final OA | TECNIFAR - INDUSTRIA TECNICA FARMACEUTICA, S.A. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy